BIO Financial Facts
Research and development expense: 52.17MGross profit: 280.23M
See Full Income Statement
Other long-term liabilities: 415.61M
Other current liabilities: 132.14M
See Full Balance Sheet
Bio-Rad Laboratories, Inc. (BIO) Earnings
|
Expand Research on BIO
| Next EPS Date | 7/30/26 | EPS Growth Rate | -30.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +15.5% | Revenue Growth Rate | -4.3% |
| Average % Move 1-Wk after EPS | -2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | $1.81 | N/A | N/A | $623.89M | N/A | N/A | N/A | ||
| 4/30/26 | Q126 | $1.89 | $1.84 | +$0.05 | $592.1M | $586.97M | N/A |  | | Details | |
| 2/12/26 | Q425 | $2.51 | $2.71 | -$0.20 | $693.2M | $692.96M | N/A | | | Details | |
| 10/29/25 | Q325 | $2.26 | $1.95 | +$0.31 | $653M | $652.24M | N/A | | | Details | |
| 7/31/25 | Q225 | $2.61 | $1.73 | +$0.88 | $651.6M | $615.2M | N/A | | | Details | |
| 5/1/25 | Q125 | $2.54 | $1.80 | +$0.74 | $585.4M | $573.22M | N/A | | | Details | |
| 2/13/25 | Q424 | $2.90 | $2.86 | +$0.04 | $667.5M | $681.29M | N/A | | | Details | |
| 10/30/24 | Q324 | $2.01 | $1.16 | +$0.85 | $649.7M | $628.18M | N/A | | | Details |
